Public annual accounts

Pharmacie Delvigne financials

Name: Pharmacie Delvigne financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Pharmacie Delvigne, with comparable measures and links to available source documents.

Company overview

Registry number

0408150561

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Pharmacie Delvigne

2025 versus 2024

Operating line: €136,088
EBITDA: €51,457
Total assets: €348,359
Equity: €175,192

EBITDA margin +37.8% · Equity ratio +50.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€136,088	€51,457	€348,359	€175,192	-
202431 Dec 2024	€114,107	€39,628	€314,739	€155,010	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report